Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY:A)

123.28 -0.89 (-0.72%)
Official Closing Price Updated: 7:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. 
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today
Via Benzinga
Bio-Techne: Commitment to Investor Contentment with Steadfast Earnings Performance
Via Benzinga
Agilent Technologies Stock Getting Closer To Key Technical Benchmark
Agilent Technologies stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 65 to 71. 
Via Investor's Business Daily
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
Via Benzinga
Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?
Stocks dipped modestly following a report indicating a marginal downward revision in the U.S. economic growth rate for the last quarter of the year. 
Via Benzinga
Topics Economy
Assessing Agilent Technologies: Insights From 6 Financial Analysts
Via Benzinga
Nasdaq, S&P 500 Futures Decline As Traders Await GDP Data, Fed Speeches; Bitcoin Eyes $60K Milestone: Analysts Highlight Small-Cap Gains As Sign Of Robust Economy
Sentiments turn negative on Wednesday after the mixed performance in the previous session, as the focus shifts to some key Main Street data. Traders may prefer to move to the sidelines to see off some... 
Via Benzinga
Topics Economy Stocks
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Expert Ratings For Agilent Technologies
Via Benzinga
Agilent Technologies Demonstrates Strong Performance and Increased Profits, Maximizing Returns for Shareholders
Via Benzinga
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday?
On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations. 
Via Benzinga
Topics Stocks
Nasdaq, S&P 500 Futures Grind Higher After Pause, Bitcoin Tops $56K: Analyst Spotlights 'Big Takeaway' That Augurs Well For Market
U.S. stocks are poised for a potential rebound on Tuesday after facing concerns about valuations in the previous session. 
Via Benzinga
Topics Stocks
Bio-Techne: Bolstering Investor Value with Reduced Dividends and Amplified Earnings
By the end of today, February 26, 2024, Bio-Techne (NASDAQ:TECH) is set to deliver a dividend payout of $0.08 per share, equating to an annualized dividend yield of 0.46%. 
Via Benzinga
Here's How Much $1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth Today
Via Benzinga
Looking Into Agilent Technologies's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $900 Today
Via Benzinga
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years
Via Benzinga
The 3 Most Promising Picks in Manufacturing Stocks for 2024
With our strengthening economy, you need to invest in these three top manufacturing stocks. They will deliver strong profits. 
Via InvestorPlace
Topics Economy
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing... 
Via Benzinga
Analyst Ratings for Agilent Technologies
Via Benzinga
Here's How Much $100 Invested In Agilent Technologies 15 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About Agilent Technologies?
Via Benzinga
$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Analyst Expectations for Agilent Technologies's Future
Via Benzinga
Goldman Sachs Maintains Buy Rating for Agilent Technologies: Here's What You Need To Know
Via Benzinga
Advancing with Stability: Bio-Techne Benefits Investors with Growing Earnings and Stable Payouts
By the close of today, November 24, 2023, Bio-Techne (NASDAQ:TECH) will issue a dividend payout of $0.08 per share, resulting in an annualized dividend yield of 0.56%. Only those investors who owned... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.